BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Breast Cancer
,
Hypothalamus
,
Metabolism of nitric oxide
,
Lipitor
,
rs3825942
,
IGF1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
amyloid fibril
Summary
General Info
Curated Studies
Most Correlated Studies
Dopaminergic neurons treated with de novo, PD-amplified or MSA-amplified α-synuclein fibrils
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Vibrational Optical Activity of Amyloid Fibrils.
Supersaturation, a Critical Factor Underlying Proteostasis of Amyloid Fibril Formation.
Pathological and Functional Amyloid Fibrils-Part I.
A coarse-grained molecular model of amyloid fibrils systems.
Nucleation and Growth of Amyloid Fibrils.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Escitalopram Effects on CSF Amyloid Beta
Carpal Tunnel Syndrome and Amyloid Cardiomyopathy
Longitudinal Study of Brain Amyloid imaGing in MEMENTO
Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy
Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ